Cargando…

Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019

In January 2019, two influenza A(H3N2) viruses carrying an I38T substitution in the polymerase acidic subunit (PA), which confers reduced susceptibility to baloxavir, were detected from epidemiologically unrelated hospitalised children in Japan. The viruses exhibited reduced susceptibility to baloxa...

Descripción completa

Detalles Bibliográficos
Autores principales: Takashita, Emi, Kawakami, Chiharu, Ogawa, Rie, Morita, Hiroko, Fujisaki, Seiichiro, Shirakura, Masayuki, Miura, Hideka, Nakamura, Kazuya, Kishida, Noriko, Kuwahara, Tomoko, Ota, Akira, Togashi, Hayato, Saito, Ayako, Mitamura, Keiko, Abe, Takashi, Ichikawa, Masataka, Yamazaki, Masahiko, Watanabe, Shinji, Odagiri, Takato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440584/
https://www.ncbi.nlm.nih.gov/pubmed/30914078
http://dx.doi.org/10.2807/1560-7917.ES.2019.24.12.1900170
_version_ 1783407414101409792
author Takashita, Emi
Kawakami, Chiharu
Ogawa, Rie
Morita, Hiroko
Fujisaki, Seiichiro
Shirakura, Masayuki
Miura, Hideka
Nakamura, Kazuya
Kishida, Noriko
Kuwahara, Tomoko
Ota, Akira
Togashi, Hayato
Saito, Ayako
Mitamura, Keiko
Abe, Takashi
Ichikawa, Masataka
Yamazaki, Masahiko
Watanabe, Shinji
Odagiri, Takato
author_facet Takashita, Emi
Kawakami, Chiharu
Ogawa, Rie
Morita, Hiroko
Fujisaki, Seiichiro
Shirakura, Masayuki
Miura, Hideka
Nakamura, Kazuya
Kishida, Noriko
Kuwahara, Tomoko
Ota, Akira
Togashi, Hayato
Saito, Ayako
Mitamura, Keiko
Abe, Takashi
Ichikawa, Masataka
Yamazaki, Masahiko
Watanabe, Shinji
Odagiri, Takato
author_sort Takashita, Emi
collection PubMed
description In January 2019, two influenza A(H3N2) viruses carrying an I38T substitution in the polymerase acidic subunit (PA), which confers reduced susceptibility to baloxavir, were detected from epidemiologically unrelated hospitalised children in Japan. The viruses exhibited reduced susceptibility to baloxavir but were susceptible to neuraminidase inhibitors. Only one of the two children had been treated with baloxavir. An epidemiological analysis suggests possible transmission of the PA I38T mutant A(H3N2) virus among humans.
format Online
Article
Text
id pubmed-6440584
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-64405842019-08-08 Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019 Takashita, Emi Kawakami, Chiharu Ogawa, Rie Morita, Hiroko Fujisaki, Seiichiro Shirakura, Masayuki Miura, Hideka Nakamura, Kazuya Kishida, Noriko Kuwahara, Tomoko Ota, Akira Togashi, Hayato Saito, Ayako Mitamura, Keiko Abe, Takashi Ichikawa, Masataka Yamazaki, Masahiko Watanabe, Shinji Odagiri, Takato Euro Surveill Rapid Communication In January 2019, two influenza A(H3N2) viruses carrying an I38T substitution in the polymerase acidic subunit (PA), which confers reduced susceptibility to baloxavir, were detected from epidemiologically unrelated hospitalised children in Japan. The viruses exhibited reduced susceptibility to baloxavir but were susceptible to neuraminidase inhibitors. Only one of the two children had been treated with baloxavir. An epidemiological analysis suggests possible transmission of the PA I38T mutant A(H3N2) virus among humans. European Centre for Disease Prevention and Control (ECDC) 2019-03-21 /pmc/articles/PMC6440584/ /pubmed/30914078 http://dx.doi.org/10.2807/1560-7917.ES.2019.24.12.1900170 Text en This article is copyright of the authors or their affiliated institutions, 2019. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Rapid Communication
Takashita, Emi
Kawakami, Chiharu
Ogawa, Rie
Morita, Hiroko
Fujisaki, Seiichiro
Shirakura, Masayuki
Miura, Hideka
Nakamura, Kazuya
Kishida, Noriko
Kuwahara, Tomoko
Ota, Akira
Togashi, Hayato
Saito, Ayako
Mitamura, Keiko
Abe, Takashi
Ichikawa, Masataka
Yamazaki, Masahiko
Watanabe, Shinji
Odagiri, Takato
Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019
title Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019
title_full Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019
title_fullStr Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019
title_full_unstemmed Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019
title_short Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019
title_sort influenza a(h3n2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit i38t substitution detected from a hospitalised child without prior baloxavir treatment, japan, january 2019
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440584/
https://www.ncbi.nlm.nih.gov/pubmed/30914078
http://dx.doi.org/10.2807/1560-7917.ES.2019.24.12.1900170
work_keys_str_mv AT takashitaemi influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT kawakamichiharu influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT ogawarie influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT moritahiroko influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT fujisakiseiichiro influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT shirakuramasayuki influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT miurahideka influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT nakamurakazuya influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT kishidanoriko influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT kuwaharatomoko influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT otaakira influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT togashihayato influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT saitoayako influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT mitamurakeiko influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT abetakashi influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT ichikawamasataka influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT yamazakimasahiko influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT watanabeshinji influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019
AT odagiritakato influenzaah3n2virusexhibitingreducedsusceptibilitytobaloxavirduetoapolymeraseacidicsubuniti38tsubstitutiondetectedfromahospitalisedchildwithoutpriorbaloxavirtreatmentjapanjanuary2019